OR WAIT null SECS
© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
May 11, 2021
Dr Arshad Khanani highlights various strategies currently under investigation for the treatment of age-related macular degeneration and explains the impact long-term data and real-world evidence has on his treatment decisions.
Considerations for treating patients with diabetes who have wet age-related macular degeneration with faricimab to reduce treatment burden based on results of recent clinical trials.
May 04, 2021
An overview of key clinical trials that have explored the potential of faricimab as a treatment option for patients with wet age-related macular degeneration.
The rationale for studying faricimab, a bispecific antibody that targets 2 distinct pathways, as a treatment option for patients with wet age-related macular degeneration.